SEC Form 13F
| Report period | 2024-12-31 |
|---|---|
| Publicly available | 2025-02-15 |
| Reported value | $210,946,304 |
| Positions | 4 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| REVOLUTION MEDICINES INC | RVMD | COM | $96,061,788 | 2,196,200 |
| BIRKENSTOCK HOLDING PLC | BIRK | COM SHS | $57,226,600 | 1,010,000 |
| LINEAGE INC | LINE | COM | $35,142,000 | 600,000 |
| NEUMORA THERAPEUTICS INC. | NMRA | COM | $22,515,916 | 2,124,143 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.